Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo

• Auteurs principaux: Bo Zhou (Auteur), Meng Xia (Auteur), Bin Wang (Auteur), Niresh Thapa (Auteur), Lijuan Gan (Auteur), Chaoyang Sun (Auteur), Ensong Guo (Auteur), Jia Huang (Auteur), Yulan Lu (Auteur), Hongbin Cai (Auteur)
• Format: Livre
• Publié: BMC, 2019-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background Cisplatin-based chemotherapy is the first-line treatment for ovarian cancer. However, acquired resistance to cisplatin treatment often occurs in epithelial ovarian cancer, and effective and practical methods for overcoming this obstacle are urgently needed. The study aimed to dem...